Skip to content
NAD+ Picks
← Research
Evidence

NMN supplements: what the trials show, and what to check before you buy

NMN is absorbed and raises NAD⁺ — that much is settled. What three systematic reviews found about glucose, lipids, muscle and body weight is the part the labels leave out, and it should shape what you pay.

Michael Reyes8 min read
What the pooled NMN trials foundBlood NAD⁺rises, dose-dependentlyGlucose, HbA1c, lipidsno significant effectMuscle mass and gripno significant effectAdverse eventsno increase vs placeboPooled across randomized trials in three published systematic reviews. Single trials disagree; pools rarely do.

An NMN supplement is a capsule or powder of nicotinamide mononucleotide, a molecule your cells convert into NAD⁺ in a single enzymatic step. Roughly 250 to 1,000 mg a day is what most products sell, and$17 to $249 a month is what the brands we have verified charge. The bottles do not hold the same amount, though, so we also rank them by cost per gram of actual NMN, where the spread is about twenty-fold. This page is about what you get for that, judged by the trials rather than the label.

The short version: the absorption claim is true, the benefit claims mostly are not established, and NMN is still a better buy than an NAD⁺ injection on both evidence and price. Those three facts do not usually appear on the same page.

What the individual trials found

There are more human trials of NMN than skeptics assume and fewer than sellers imply. The strongest is a randomized, double-blind, placebo-controlled, multicenter trial of 80 healthy middle-aged adults (n = 80) on placebo, 300, 600 or 900 mg daily for 60 days. Blood NAD rose significantly in every NMN arm at day 30 and day 60 against placebo and baseline (all p ≤ 0.001), and the increase in six-minute walking distance was significantly greater than placebo in all three dose groups (all p < 0.01) [1].

A Japanese trial gave 250 mg daily to healthy older men for 6 or 12 weeks. Blood NAD⁺ and its metabolites rose significantly; gait speed and left-hand grip showed what the authors themselves called nominally significant improvements needing validation in larger studies; body composition did not change [2]. A second trial of 250 mg daily for 12 weeks in 60 older adults is more instructive still, because of how it is structured: its primary outcome — a stepping test — showed no significant difference from placebo at either 4 or 12 weeks. The results that made the headline, a shorter 4-meter walking time and better sleep quality scores, were secondary [3].

In 48 amateur runners training five or six times a week, six weeks of 300, 600 or 1,200 mg daily raised oxygen uptake and power at both ventilatory thresholds more than placebo in the medium and high dose groups — while producing no difference in VO₂max, oxygen pulse or peak power [4]. A genuinely interesting result, and a narrower one than “NMN improves fitness.”

What happens when you pool them

This is the section other buyer’s guides leave out, and it is the one that should shape your decision.

Eight randomized trials of NMN — 342 mostly non-diabetic middle-aged and older adults, doses of 250 to 2,000 mg daily, 14 days to 12 weeks — were pooled for glucose and lipid outcomes. The meta-analysis found no significant benefit on fasting glucose, fasting insulin, glycated hemoglobin, HOMA-IR or the lipid profile [5].

A separate meta-analysis pooled the muscle outcomes in adults over 60. NMN showed no significant effect on skeletal muscle index (mean difference −0.42, 95% CI −0.99 to 0.14, p = 0.14), grip strength, gait speed (mean difference −0.01, 95% CI −0.08 to 0.06, p = 0.79) or the five-time chair stand test, and the authors concluded that current evidence does not support NMN for preserving muscle mass and function in that age group [6].

And a 2026 review of 15 trials, running to 24 weeks, found NMN well tolerated — no increase in overall, serious or system-specific adverse events, no elevation of ALT or AST — with no significant effect on body weight, BMI, fasting glucose, HbA1c, lipid profiles or systolic blood pressure. Diastolic blood pressure fell slightly [7].

The safety picture

Better than the efficacy picture, which is the usual shape for a supplement. A dedicated safety trial gave 1,250 mg of β-NMN once daily for up to four weeks to 31 healthy adults aged 20 to 65 and found no changes exceeding normal physiological variation across anthropometry, hematology, biochemistry, urine and body composition, and no severe adverse events [8]. That is short-term data in healthy people, not a long-term safety record — see what is and is not known about NAD⁺ safety before you start.

What to look for on a label

Four questions do most of the work, and none of them are about the marketing.

Does the daily dose match a trial dose? The published trials used 250, 300, 600, 900, 1,200 and 1,250 mg daily. A product at 125 mg is below everything that has been studied. We keep the full list, with the trial each number comes from, on the dosage page.

Is the milligram figure for NMN itself? In a proprietary blend, the number on the front is the blend, not the ingredient, and you cannot compare it with anything.

What does it cost per gram? This is the only honest way to compare two NMN products, and it reorders the market when you run it — our price comparison and cost calculator exist for exactly that.

NMN or NR? NR has the longer trial record and a settled regulatory position in the United States; NMN’s status as a lawful dietary supplement ingredient is unresolved, which affects whether you can reliably buy it rather than whether it works. We compare the two directly in NMN vs NR, and Tru Niagen is the NR product whose ingredient most of the published NR research actually used.

Our read

If you want to take an NAD⁺ precursor, NMN is a reasonable thing to take: it is absorbed, it raises NAD⁺, and the short-term safety data is clean. Buy it understanding that the pooled evidence for metabolic, muscular and body-composition benefit in healthy adults is currently null, and that anyone telling you otherwise is quoting single trials and skipping the meta-analyses.

What we would not do is pay four times as much for the same molecule in a syringe. The evidence ranking in this category runs opposite to the price ranking, and the oral precursor page is where that shows up most clearly.

Frequently asked

Do NMN supplements actually work?
They do the mechanistic thing reliably: randomized trials show blood NAD⁺ rising dose-dependently, at p ≤ 0.001 in the largest of them. Whether anything follows is less settled. Pooled across eight trials there was no significant benefit on glucose, insulin, HbA1c, HOMA-IR or lipids; pooled across trials in older adults there was no significant effect on muscle mass, grip strength or gait speed.
What is a typical NMN supplement dose?
Products commonly sell 250 to 1,000 mg daily. The published human trials used 250, 300, 600, 900, 1,200 and 1,250 mg daily, and a 2026 review covered trials ranging from 250 to 2,000 mg daily for 14 days to 24 weeks. We report those because they were administered in studies, not as a recommendation — the dose that suits you is a question for a clinician.
Is NMN safe?
The short-term data is clean. A dedicated safety trial of 1,250 mg once daily for up to four weeks in 31 healthy adults found no changes beyond normal physiological variation and no severe adverse events, and a 2026 review of 15 trials found no increase in overall, serious or system-specific adverse events and no elevation of liver enzymes. There is no long-term safety record, because no long-term trial has been run.
NMN or NR — which should I buy?
NR has the longer published trial record and a settled regulatory position in the United States. NMN's status as a lawful dietary supplement ingredient in the US is unresolved, which can affect availability rather than efficacy. On measured NAD⁺ increases, both work.
What should I check on an NMN label?
Whether the daily dose matches a dose used in a published trial; whether the milligram figure is for NMN itself rather than a proprietary blend; what it costs per gram, which is the only way to compare two products; and whether you actually want NMN rather than NR.

Sources

  1. [1] Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial GeroScience. PMID 36482258
  2. [2] Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men npj Aging. PMID 35927255
  3. [3] Morifuji M, Higashi S, Ebihara S, et al. (2024). Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study GeroScience. PMID 38789831
  4. [4] Liao B, Zhao Y, Wang D, et al. (2021). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study Journal of the International Society of Sports Nutrition. PMID 34238308
  5. [5] Chen F, Zhou D, Kong AP, et al. (2024). Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials Current Diabetes Reports. PMID 39531138
  6. [6] Prokopidis K, Moriarty F, Bahat G, et al. (2025). The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis Journal of Cachexia, Sarcopenia and Muscle. PMID 40275690
  7. [7] Yang W, Huang J, Tang Z, et al. (2026). Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis Nutrients. PMID 42514320
  8. [8] Fukamizu Y, Uchida Y, Shigekawa A, et al. (2022). Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women Scientific Reports. PMID 36002548

Where to get it

Oral NAD⁺ precursors (NR and NMN)

The cheapest route with the strongest human data — and the one we earn nothing from.

Compare providers →

More in Evidence